Cargando…

Liver Transplant Tolerance and Its Application to the Clinic: Can We Exploit the High Dose Effect?

The tolerogenic properties of the liver have long been recognised, especially in regard to transplantation. Spontaneous acceptance of liver grafts occurs in a number of experimental models and also in a proportion of clinical transplant recipients. Liver graft acceptance results from donor antigen-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunningham, Eithne C., Sharland, Alexandra F., Bishop, G. Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836300/ https://www.ncbi.nlm.nih.gov/pubmed/24307909 http://dx.doi.org/10.1155/2013/419692

Ejemplares similares

Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?
por: Safinia, Niloufar, et al.
Publicado: (2021)

Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?
por: Halma, Jennifer, et al.
Publicado: (2021)

Can we reduce oxidative stress with liver transplantation?
por: Aydin, Mesut, et al.
Publicado: (2021)

Alloactivation of Naïve CD4(+)CD8(−)CD25(+)T Regulatory Cells: Expression of CD8α Identifies Potent Suppressor Cells That Can Promote Transplant Tolerance Induction
por: Verma, Nirupama D., et al.
Publicado: (2019)

Clinical Transplantation and Tolerance: Are We There Yet?
por: Saidi, R. F., et al.
Publicado: (2014)

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!
por: Ajani, Jaffer A.
Publicado: (2007)

Biofortification: how can we exploit plant science and biotechnology to reduce micronutrient deficiencies?
por: Murgia, Irene, et al.
Publicado: (2013)

Can We Exploit β-Lactamases Intrinsic Dynamics for Designing More Effective Inhibitors?
por: Gianquinto, Eleonora, et al.
Publicado: (2020)

Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?
por: Copsel, Sabrina N., et al.
Publicado: (2022)

How can we exploit above–belowground interactions to assist in addressing the challenges of food security?
por: Orrell, Peter, et al.
Publicado: (2013)

Strategies for Liver Transplantation Tolerance
por: Cvetkovski, Filip, et al.
Publicado: (2021)

Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?
por: Rebollo‐Mesa, I., et al.
Publicado: (2016)

ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
por: Hsu, Shih-Chao, et al.
Publicado: (2020)

Antenatal steroids: can we optimize the dose?
por: Romejko-Wolniewicz, Ewa, et al.
Publicado: (2014)

Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?
por: Gagelmann, Nico, et al.
Publicado: (2021)

The Role of Diverse Liver Cells in Liver Transplantation Tolerance
por: Jiang, Yanzhi, et al.
Publicado: (2020)

Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
por: Du, Xiaoxiao, et al.
Publicado: (2020)

Industrial Fruits By-Products and Their Antioxidant Profile: Can They Be Exploited for Industrial Food Applications?
por: Barbosa, Cássia H., et al.
Publicado: (2021)

Microbes and cancer geography: can we exploit recent lessons from the gut system to oral cancer context?
por: GARLET, Gustavo P., et al.
Publicado: (2014)

How can we reduce the impact of COVID-19 pandemic on timely access to liver transplantation in children?
por: Reddy, Mettu Srinivas, et al.
Publicado: (2021)

Cord Blood Transplantation: Can We Make it Better?
por: Metheny, Leland, et al.
Publicado: (2013)

First Latin uterine transplantation: we can do it!
por: Soares, José Maria, et al.
Publicado: (2016)

Hand transplantation: can we balance the risks and benefits?
por: Kay, Simon P. J., et al.
Publicado: (2023)

Immune Checkpoint Inhibitor Dosing: Can We Go Lower Without Compromising Clinical Efficacy?
por: Renner, Alex, et al.
Publicado: (2019)

Loss of ischemic tolerance with age: can we protect an old kidney
por: Plotnikov, Egor
Publicado: (2021)

Loss of ischemic tolerance with age: can we protect an old kidney
por: Plotnikov, Egor
Publicado: (2021)

Can we improve the chilling tolerance of maize photosynthesis through breeding?
por: Burnett, Angela C, et al.
Publicado: (2022)

Can we cure relapsed/refractory Hodgkin lymphoma without a stem cell transplant?
por: Mei, Matthew G., et al.
Publicado: (2023)

Exploitation of Diversity within Crops—the Key to Disease Tolerance?
por: Newton, Adrian C.
Publicado: (2016)

Exploitation of Drought Tolerance-Related Genes for Crop Improvement
por: Wang, Jingyi, et al.
Publicado: (2021)

Exploiting Tomato Genotypes to Understand Heat Stress Tolerance
por: Fernández-Crespo, Emma, et al.
Publicado: (2022)

Tolerance in liver transplantation: Biomarkers and clinical relevance
por: Baroja-Mazo, Alberto, et al.
Publicado: (2016)

Transplant Tolerance Induction: Insights From the Liver
por: Dai, Helong, et al.
Publicado: (2020)

Induction Phase of Spontaneous Liver Transplant Tolerance
por: McCaughan, Geoffrey W., et al.
Publicado: (2020)

High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
por: Sakpal, Sujit Vijay, et al.
Publicado: (2019)

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
por: Jiang, Jingyu, et al.
Publicado: (2023)

Can we shift belief in the ‘Law of Small Numbers’?
por: Bishop, D. V. M., et al.
Publicado: (2022)

Exploiting lipotoxicity for the treatment of liver cancer
por: Rudalska, Ramona, et al.
Publicado: (2021)

Can We Quantify If It’s a CURE?
por: Beck, Christopher W., et al.
Publicado: (2023)

Thrombocytopenia after liver transplantation: Should we care?
por: Takahashi, Kazuhiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sb830qhdmon1js0f5ate61ep3m